Abstract: The present invention is directed to novel dihydropyrimidin-2(1H)-one compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: The present invention is directed to novel dihydropyridin-2(1H)-one compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors and/or Neurokinin-3 (NK3) receptor antagonists, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: The present invention is directed to novel substituted bicyclic aromatic compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: The present invention discloses a cathode material for lithium ion secondary battery. The cathode material is in the form of powder particles. The powder particle includes a bulk portion and a coating portion coated on the outer surface of the bulk portion. The bulk portion is formed of at least one first cathode material which is a lithium-nickel based composite oxide. The first cathode material has electrochemical activity and has high charging-discharging specific capacity at a charged voltage of 4.2V versus Li/Li+. The coating portion is formed of at least one second cathode material. The second cathode material has no electrochemical activity or has low charging-discharging specific capacity at a charged voltage of 4.2V versus Li/Li+. Lithium ion secondary battery using the cathode material has high energy density, cycling stability, security, and output power.

Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

Abstract: The present invention is directed to novel substituted bicyclic aromatic compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: Automatically associating information technology resource patterns with specific information technology products by receiving a set of data about information technology assets, matching a subset of that data to a pattern in a set of patterns, determining that the subset of the data represents a product associated with that pattern, reporting this determination; receiving feedback on the accuracy of the determination, and updating pattern set information in response to that feedback.

Abstract: The embodiments of the present invention discloses a method for simulating multitouch with two joysticks, comprising: receiving movement parameters input during movement of the first joystick and the second joystick; obtaining movement traces of a first mouse pointer corresponding to the first joystick and a second mouse pointer corresponding to the second joystick on the graphical interface of a terminal unit, according to the movement parameters; and, generating a corresponding touch gesture signal, according to the movement traces of the first mouse pointer and the second mouse pointer. With the present invention, non-touch screen display terminals can support multitouch, and thereby the compatibility of such terminal units is improved.

Abstract: Disclosed in the embodiments of the present invention is a key function conversion method, comprising: detecting a click operation sent by a first key; searching for a second key associated to the first key in a preset key mapping table; converting the click operation sent by the first key into a click operation sent by the second key; and, generating a function trigger signal corresponding to the click operation sent by the second key. A key function conversion device and a key function conversion electronic equipment are also disclosed in the embodiments of the present invention. With the present invention, the compatibility of a terminal unit with application programs can be improved.

Abstract: A method for backing up or restoring a virtual machine is provided. The backup method includes creating a virtual machine having a first and a second union file system directory. The first directory read only stores a virtual machine base operating system file. The second directory is readable and writable and stores modifications to the base operating system file, and new files generated during running of the virtual machine. The virtual machine preferentially reads and writes the second directory. When a request to back up the virtual machine is received, the data in the second directory is backed up. The restore method includes preparing a virtual machine for restoring data. When a request to restore the virtual machine is received, the backup data of the second directory is obtained and restored to the second directory of the prepared virtual machine.

Abstract: The present invention is directed to novel substituted bicyclic aromatic compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

Abstract: The present invention is directed to novel quinoline compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

Abstract: The present invention is directed to novel quinoline compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

Abstract: The present invention is directed to novel dihydropyrimidin-2(1H)-one compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: The present invention is directed to novel substituted bicyclic aromatic compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.